A bacterial genome reveals new targets to combat infectious disease
More than a billion people are at risk for infection with filarial nematodes, parasites that cause elephantiasis, African river blindness, and other debilitating diseases in more than 150 million people worldwide. The nematodes themselves play host to bacteria that live within their cells, but in this case, the relationship is classic mutualism, with each benefiting from the other. Indeed, the Wo...Study reveals candidate targets for anti-retroviral therapeutics
The increased frequency of drug resistance in isolates of the AIDS virus, HIV, makes identification of new antiviral targets an urgent necessity. Host genes required to support the replication of HIV are a potential source of such novel targets, but relatively few appropriate target genes have been identified in animal cells thus far. A new study, conducted by Dr. Suzanne Sandmeyer and colleagues...'Smart drug' targets deadly brain cancer
A study led by Mayo Clinic researchers and conducted by the North Central Cancer Treatment Group (NCCTG) reports that a new "smart" drug treatment for an incurable form of recurrent brain cancer slowed tumor growth in more than one-third of the 65 adult patients who tried it. The same research team also developed a screening technique to help predict which patients will respond best to this treat...NHGRI targets 12 more organisms for genome sequencing
The National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), announced today that the Large-Scale Sequencing Research Network will begin sequencing 12 more strategically selected organisms, including the marmoset, a skate and several important insects, as part of its ongoing effort to expand understanding of the human genome. The National Advisory...Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (USF), has discovered a new use for an old, previously discredited anti-cancer drug that could add another weapon in the arsenal against several cancers, including tumors of the breast, ovary, colon, skin and prostate. The compound, tricirbine, was tested at various cancer cen...Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
DNAPolymerase Stratagene DNA polymerase* by making simple modifications to PCR reactionconditions. In this update, we d...Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.
Recent advances in combinatorial chemistry and genomics programs have led to an unprecedented increase in both the number of compounds and potential drug targets that can be screened. The development of automated liquid h...Calcium Plus Assay Kit, Superior Detection for Specialized Targets
HIGHER MAXIMUM SIGNAL RAPID PROCEDURE COMPATIBLE WITH MORE TARGETS SUITABLE FOR HTS APPLICATONS The Calcium Plus Assay Kit provides a reliableand homogeneous method for detecting changesin intracellula...Online scam targets credit union members
According to a notice from , the trade association for more than 270 credit unions...Scios Inc. targets drug giants in arthritis war
Scios Inc. , a small California biotechnology company, is racing giant rivals to bring a pill to market that would displace injectable anti-inflammatory drugs and set a new standard in arthritis treatment. Scios' ambitions are much larger than its market capitalization of a little more than $1 billion. That's because the first company to commercialize an oral version of today's dominant i...Research Targets treatment for dementia and brain injuries
Researchers at Queensland Brain Institute (QBI) have now found a process that could lead to development// of repair mechanisms for people suffering from dementia and acquired brain injury. The research focuses on the hippocampus, the part of the brain commonly associated with memory function and where the brain's ability to regenerate nerve cells or neurons is known to degenerate wit...Cancer Treatments Fall Short Of Targets
A report released by the Scottish Executive says that almost 25 percent of cancer patients in the country are not being treated for their condition within the targeted time of two months. //The current data is centered around the period between April to June 2005. The report said that just about 75 percent of all cancer patients were treated in that period. But the rate fell to 60 percen...India Targets Eliminating Leprosy
Health Officials in India have revealed that the country is moving further towards eliminating leprosy. The country has set itself a target of less than one leprosy infected person for every 10,000 people. During the early 1980s, when the Multi Drug Therapy (MDT) was yet to be introduced in the country, the figures were at 57.6 cases for every 10,000 people. This rate has now come down to...Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
A new study was conducted to understand the biochemistry and structure of a protein-cleaving complex (proteasome) that is essential to the TB bacterium’s survival. The findings were published in the journal Molecular Microbiology. // The study’s main aim was to design effective treatment for the disease tuberculosis (TB). The study was done by scientists from the U.S. Department of Energy...TargetScan Targeted Prostate Biopsy System
Description:TargetScan(R) is the latest innovation in prostate mapping, biopsy and cancer treatment guidance. Combining 3-D image acquisition with a stationary probe, this new technology helps physicians plan and execute targeted prostate biopsies -- potentially improving patients' cancer treatment outcomes with less-invasive procedures....Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
Data Presented at Society for Biomolecular Sciences Conference THE WOODLANDS, Texas, April 18, 2007 /PRNewswire-FirstCall/ --Lexicon Genetics Incorporated announced that data was presentedtoday highlighting potential therapeutic targets related to itscollaboration with Genentech, Inc. at the Society for BiomolecularSciences 13th Annual Conference & Exhibition in Montreal,Canada. These...